Your browser doesn't support javascript.
loading
Altered T-cell subset repertoire affects treatment outcome of patients with myelofibrosis.
Veletic, Ivo; Prijic, Sanja; Manshouri, Taghi; Nogueras-Gonzalez, Graciela M; Verstovsek, Srdan; Estrov, Zeev.
Affiliation
  • Veletic I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Prijic S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Manshouri T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nogueras-Gonzalez GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Haematologica ; 106(9): 2384-2396, 2021 09 01.
Article in En | MEDLINE | ID: mdl-32732359
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Primary Myelofibrosis Limits: Humans Language: En Journal: Haematologica Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Primary Myelofibrosis Limits: Humans Language: En Journal: Haematologica Year: 2021 Type: Article Affiliation country: United States